Drug Enforcement Administration March 2024 – Federal Register Recent Federal Regulation Documents

Bulk Manufacturer of Controlled Substances Application: Purisys, LLC
Document Number: 2024-06185
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
Purisys, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Usona Institute, Inc
Document Number: 2024-06184
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
Usona Institute, Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: SpecGx LLC
Document Number: 2024-06181
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Sharp Clinical Services, LLC
Document Number: 2024-06179
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Caligor Coghlan Pharma Services
Document Number: 2024-06178
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
Caligor Coghlan Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Stepan Company
Document Number: 2024-06177
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
Stepan Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Restek Corporation
Document Number: 2024-06193
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Halo Pharmaceutical Inc.
Document Number: 2024-06190
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
Halo Pharmaceutical Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Promega Corporation
Document Number: 2024-06189
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Hybrid Pharma
Document Number: 2024-06188
Type: Notice
Date: 2024-03-25
Agency: Drug Enforcement Administration, Department of Justice
Hybrid Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I
Document Number: 2024-05543
Type: Rule
Date: 2024-03-15
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final order, the Administrator of the Drug Enforcement Administration is permanently placing 1-(2-methyl- 4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one (commonly known as 2-methyl AP-237), including its optical and geometric isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. This scheduling action discharges the United States' obligations under the Single Convention on Narcotic Drugs (1961). This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle 2-methyl AP-237.
Mark Fenzl, D.O.; Decision and Order
Document Number: 2024-05099
Type: Notice
Date: 2024-03-11
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC
Document Number: 2024-04747
Type: Notice
Date: 2024-03-06
Agency: Drug Enforcement Administration, Department of Justice
Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Nusachi Labs, LLC
Document Number: 2024-04743
Type: Notice
Date: 2024-03-06
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Importer of Controlled Substances Application: Benuvia Operations, LLC
Document Number: 2024-04757
Type: Notice
Date: 2024-03-06
Agency: Drug Enforcement Administration, Department of Justice
Benuvia Operations, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Sigma Aldrich Company LLC
Document Number: 2024-04756
Type: Notice
Date: 2024-03-06
Agency: Drug Enforcement Administration, Department of Justice
Sigma Aldrich Company LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry
Document Number: 2024-04755
Type: Notice
Date: 2024-03-06
Agency: Drug Enforcement Administration, Department of Justice
Organic Consultants LLC DBA Cascade Chemistry has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Stepan Company
Document Number: 2024-04754
Type: Notice
Date: 2024-03-06
Agency: Drug Enforcement Administration, Department of Justice
Stepan Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: AndersonBrecon Inc. dba PCI Pharma Services
Document Number: 2024-04753
Type: Notice
Date: 2024-03-06
Agency: Drug Enforcement Administration, Department of Justice
AndersonBrecon Inc. dba PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.